Gene therapy for age-related macular degeneration
Age-related macular degeneration is the most common cause of untreatable blindness in the world, and its prevalence is increasing. Current therapies for neovascular age-related macular degeneration aim to prevent growth of the abnormal retinal blood vessels that could leak and cause rapid visual los...
Main Author: | |
---|---|
Format: | Journal article |
Published: |
Elsevier
2015
|